GeneType Multi Test
A combination of geneType tests for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type 2 diabetes in a single test.
Know your risk of a serious disease to tailor a personalised prevention plan with your medical practitioner.
Our pipeline
We have a strong pipeline of tests covering a wide range of serious conditions that are currently in various stages development, accreditation and approval.
Phase 2 launch of the Genetype Multi-Risk Test
Introducing Melanoma, Pancreatic Cancer and Atrial Fibrillation
Expanding our capability, introducing NIPT and Carrier testing
Development of Epigenetics Division
- Phase 1 Methylation tests
- Phase 2 Mutation tests
Accredited For Compliance With NPAAC Standards And ISO 15189
